Source:http://linkedlifedata.com/resource/pubmed/id/19442044
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-5-15
|
pubmed:abstractText |
Omega-3 fatty acids (omega3-FA) were shown to attenuate growth and induce apoptosis in a variety of human cancer cell lines derived from colonic, pancreatic, prostate, and breast cancer. In addition, recent findings indicate that omega3-FA act synergistically with chemotherapeutic agents and may also be used to enhance tumour radiosensitivity. The mechanisms underlying the anti-tumour effects of omega3-FA are complex. Incorporation of omega3-FA in biological membranes alters the profile of lipid mediators generated during inflammatory reactions. Furthermore, omega3-FA act as ligands of nuclear peroxisome proliferator-activated receptors that attenuate transcription of NF-kappaB-dependent genes. Thereby, the cyclooxygenase-2/prostaglandin E(2)-dependent production of pro-angiogenic vascular endothelial growth factor and levels of anti-apoptotic bcl-2 and bcl-X(L) are decreased. Eicosanoid-independent pro-apoptotic pathways include enhanced lipid peroxidation, modulation of mitochondrial calcium homeostasis and enhanced production of reactive oxygen species as well as activation of p53. This review article will give a comprehensive overview over the pleiotropic actions of omega3-FA and will discuss the potential of omega3-FA and derivatives like conjugated eicosapentaenoic acid as important nutritional adjuvant therapeutics in the management of various human cancer diseases and the impact of nutritional omega-3 FA on cancer prevention.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Dietary Fats,
http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone,
http://linkedlifedata.com/resource/pubmed/chemical/Docosahexaenoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Omega-3,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoxins,
http://linkedlifedata.com/resource/pubmed/chemical/Peroxisome Proliferator-Activated...,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53,
http://linkedlifedata.com/resource/pubmed/chemical/resolvin D1
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1875-5992
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
457-70
|
pubmed:meshHeading |
pubmed-meshheading:19442044-Antineoplastic Agents,
pubmed-meshheading:19442044-Apoptosis,
pubmed-meshheading:19442044-Cell Line, Tumor,
pubmed-meshheading:19442044-Cyclooxygenase 2,
pubmed-meshheading:19442044-Dietary Fats,
pubmed-meshheading:19442044-Dinoprostone,
pubmed-meshheading:19442044-Docosahexaenoic Acids,
pubmed-meshheading:19442044-Fatty Acids, Omega-3,
pubmed-meshheading:19442044-Female,
pubmed-meshheading:19442044-Humans,
pubmed-meshheading:19442044-Lipoxins,
pubmed-meshheading:19442044-Male,
pubmed-meshheading:19442044-Neoplasms,
pubmed-meshheading:19442044-Peroxisome Proliferator-Activated Receptors,
pubmed-meshheading:19442044-Tumor Suppressor Protein p53
|
pubmed:year |
2009
|
pubmed:articleTitle |
Anticancer actions of omega-3 fatty acids--current state and future perspectives.
|
pubmed:affiliation |
Department of Physiology, Medical Faculty Carl Gustav Carus, University of Technology, Dresden, Germany. MartinaWendel@gmx.de
|
pubmed:publicationType |
Journal Article,
Review
|